CPN1 and glomerulosclerosis: This notion is supported by several lines of evidence, including the upregulation of Shh and N-Shh in the EVs isolated from damaged podocytes, and the mitigated glomerulosclerosis by Shh signaling inhibitor CPN (Figure 6).